A drug considered to be a ‘huge breakthrough’ for the treatment of Alzheimer’s, Lecanemab, has been approved for use in the UK - but it’s been announced that it won’t be available on the NHS in England.

David Thomas, Head of Policy & Public Affairs at Alzheimer’s Research UK, tells Tech & Science Daily why it’s a bittersweet moment for people living with dementia.

World-leading sleep expert and neuroscientist Professor Russell Foster from Oxford University, tells our sister podcast Brave New World, why napping is seen as controversial in the sleep science community. Listen to the full episode here.

Research suggests that the Moon’s south pole was once covered in an ocean of magma.

Also in this episode:

Heartbreak as one half of world-famous gay penguin couple dies
UK heat-related deaths predicted to soar by end of century with 3C of warming
Young inventor of accessible device pitches idea to Paralympian Ellie Challis

Follow us on X or on Threads.

Hosted on Acast. See acast.com/privacy for more information.

Lecanemab: ‘Breakthrough’ Alzheimer's drug approved for UK use